Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | LIFE MEDICAL HALL | 1 | ₹4.1 L |
| 2 | Schedule 2 | LIFE MEDICAL HALL | 1 | ₹5.6 L |
| 3 | Schedule 3 | LIFE MEDICAL HALL | 1 | ₹7.9 L |
| 4 | Schedule 4 | Synergy Associates | 1 | ₹68,850 |
| 5 | Schedule 5 | Synergy Associates | 1 | ₹1.2 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
28 Jul 2025, 10:00 amClosed
1000070684_1_91701002021_ESOMEPRAZOLE 40 MG TAB
1000070684_2_91700110000_ESOMEPRAZOLE 40MG Plus DOMPERIDONE 30MG SR CAP
1000070684_3_91701004500_ESOMOPRAZOLE 40 MG Plus LEVOSULPRIDE 75 MG SR CAPSULE
1000070684_4_91800003360_METHYLCOBALAMINE 750mcg
1000070684_5_91800005820_ATORVASTATIN 10
1000070684_6_91800005810_ATORVASTATIN 20
8052631
GEM/2025/B/6420521
Two Packet Bid
1000070684_1_91701002021_ESOMEPRAZOLE 40 MG TAB
GeM Contract
240 days
Sankar Choudhury763008Nalco Hospital, Damanjodi, Dist- Koraput
Item wise evaluation
BOQ
Awarded to Synergy Associates
₹2.6 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| 1000070684_4_91800003360_METHYLCOBALAMINE 750mcg | Lupin / PREGASTAR - M 75 | 30049099 | 15,000 EA | 4.59 | 68,850 |
| 1000070684_5_91800005820_ATORVASTATIN 10 | Lupin / CLOPITAB CV 10 | 30049079 | 15,000 EA | 7.95 | 119,250 |
| 1000070684_6_91800005810_ATORVASTATIN 20 | Lupin / CLOPITAB CV 20 | 30049079 | 5,000 EA | 14.67 | 73,350 |
Awarded to LIFE MEDICAL HALL
₹17.7 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| 1000070684_1_91701002021_ESOMEPRAZOLE 40 MG TAB | TORRENT PHARMACEUTICALS / NEXPRO 40MG | HSN not specified by seller | 60,000 EA | 6.88 | 412,800 |
| 1000070684_3_91701004500_ESOMOPRAZOLE 40 MG Plus LEVOSULPRIDE 75 MG SR CAPSULE | TORRENT PHARMACEUTICALS / NEXPRO L | HSN not specified by seller | 40,000 EA | 19.83 | 793,200 |
| 1000070684_2_91700110000_ESOMEPRAZOLE 40MG Plus DOMPERIDONE 30MG SR CAP | TORRENT PHARMACEUTICALS / NEXPRO RD 40MG | HSN not specified by seller | 70,000 NO | 8.07 | 564,900 |
4 documents required · 4 mandatory
Exempted
24 Oct 2025
7 Jul 2025
28 Jul 2025
1000070684_1_91701002021_ESOMEPRAZOLE 40 MG TAB | Brand:TORRENT PHARMACEUTICALS | Model:NEXPRO 40MG | HSN:HSN not specified by seller | Qty:60,000 EA | UnitPrice:6.88 | Amount:412,800
1000070684_3_91701004500_ESOMOPRAZOLE 40 MG Plus LEVOSULPRIDE 75 MG SR CAPSULE | Brand:TORRENT PHARMACEUTICALS | Model:NEXPRO L | HSN:HSN not specified by seller | Qty:40,000 EA | UnitPrice:19.83 | Amount:793,200
1000070684_2_91700110000_ESOMEPRAZOLE 40MG Plus DOMPERIDONE 30MG SR CAP | Brand:TORRENT PHARMACEUTICALS | Model:NEXPRO RD 40MG | HSN:HSN not specified by seller | Qty:70,000 NO | UnitPrice:8.07 | Amount:564,900
1000070684_4_91800003360_METHYLCOBALAMINE 750mcg | Brand:Lupin | Model:PREGASTAR - M 75 | HSN:30049099 | Qty:15,000 EA | UnitPrice:4.59 | Amount:68,850
1000070684_5_91800005820_ATORVASTATIN 10 | Brand:Lupin | Model:CLOPITAB CV 10 | HSN:30049079 | Qty:15,000 EA | UnitPrice:7.95 | Amount:119,250
1000070684_6_91800005810_ATORVASTATIN 20 | Brand:Lupin | Model:CLOPITAB CV 20 | HSN:30049079 | Qty:5,000 EA | UnitPrice:14.67 | Amount:73,350
contract_GEMC-511687790093457.pdf
GEM_CONTRACT • 0.09 MB
contract_GEMC-511687786268576.pdf
GEM_CONTRACT
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8052631.pdf
GEM_BID
41c2cdaf01f86c46d58c8044acb0e914.pdf
OTHER
SA8000Med_282adf29-f2e2-491a-94b21751710375339_ahemanth.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
6000063636_2025-07-05-15-29-16_e24064221dd279bca5a6f3a8cab88f11.pdf
BOQ
boq_-1000070684_2025-07-05-15-29-16_954ab1348b4a391dc8c63d3c56cc2531.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .